Autoimmune Diseases

The finding will likely help physicians develop targeted therapies for future COVID-19 patients

National survey of MS specialists finds nearly 10 percent redeployed to the front lines of COVID-19 patient care

The engineered T cells can target and attack pathogenic T cells in a mouse model of Type 1 diabetes

The first effective MS treatments became available two decades ago, but the new study is the latest to demonstrate the much greater effectiveness of a new type of treatment

New research has identified several genes that appear to drive disease risk at birth, and which could be targeted for therapeutic intervention to stop these diseases

Trial results could have implications for the treatment of numerous conditions including metabolic syndrome and autoimmune diseases

In a recent study, NIH researchers and their collaborators found that the most common biomarker of autoimmunity is significantly increasing in the US

Systemic lupus erythematosus (SLE) is a systemic rheumatic disease mainly affecting women in childbearing age, that is associated with inflammatory symptoms from multiple organs

Finding may create opportunity to test patients to avoid ineffective drugs

Lupus causes the immune system to lose the ability to differentiate between foreign agents and healthy tissue